Skip to main content

Gallbladder Disease

2
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

MSD
MSDIreland - Ballydine
1 program
1
RocuroniumPhase 41 trial
Active Trials
NCT01728584Completed127Est. Apr 2014
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
1 program
1
RocuroniumPhase 4
Intuitive Surgical
Intuitive SurgicalCA - Sunnyvale
1 program
Indocyanine greenN/A1 trial
Active Trials
NCT01410734Completed72Est. Dec 2012
Medtronic
MedtronicNJ - Phillipsburg
1 program
SILS™ port laparoscopic cholecystectomyN/A1 trial
Active Trials
NCT00832767Completed202Est. Jan 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MSDRocuronium
Intuitive SurgicalIndocyanine green
MedtronicSILS™ port laparoscopic cholecystectomy

Clinical Trials (3)

Total enrollment: 401 patients across 3 trials

NCT01728584MSDRocuronium

A Study Comparing the Use of Deep or Standard Neuromuscular Blockade in Combination With Low or Standard Insufflation Pressures in Participants Undergoing Laparoscopic Cholecystectomy (P07982)

Start: Nov 2012Est. completion: Apr 2014127 patients
Phase 4Completed

Fluorescence Imaging on the da Vinci Surgical System for Intra-operative Near Infrared Imaging of the Biliary Tree (up to 2-weeks Post-operatively)

Start: Jul 2011Est. completion: Dec 201272 patients
N/ACompleted
NCT00832767MedtronicSILS™ port laparoscopic cholecystectomy

SILS™ Port Laparoscopic Cholecystectomy Post Market Study

Start: Apr 2009Est. completion: Jan 2012202 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.